Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
46.80
+1.80 (4.00%)
Apr 16, 2025, 1:05 PM CET

Gentian Diagnostics ASA Revenue

In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M NOK with 12.52% growth. Gentian Diagnostics ASA had revenue of 42.61M in the quarter ending December 31, 2024, with 13.73% growth.

Revenue
152.07M
Revenue Growth
+12.52%
P/S Ratio
4.75
Revenue / Employee
2.41M
Employees
63
Market Cap
721.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024152.07M16.92M12.52%
Dec 31, 2023135.15M23.23M20.76%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 556.16M
Nordhealth AS 537.23M
Photocure ASA 525.39M
Vistin Pharma ASA 429.50M
ArcticZymes Technologies ASA 108.11M
Hofseth BioCare ASA 265.54M
Omda AS 426.27M
Nykode Therapeutics AS 104.04M
Revenue Rankings